VAN VLERKEN-YSLA, Lilian Emilia,HURT, Elaine Marie
申请号：
HK18110314
公开号：
HK1250958A1
申请日:
2018.08.13
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express CCL20 and/or CCR6.
